CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Webinar | Targeting Cancer Pathways: Understanding Immune Checkpoints

Read More
All Posts
Webinar-Immune-Checkpoint-Banner.jpg
In this webinar, the speakers will explore how tumors exploit immune modulatory mechanisms to generate and thrive in their own immunosuppressive microenvironment. In addition, they will:
  • Provide a historical overview of immune checkpoint research and examine the effect of mutational load on clinical response
  • Explain how PD-1 immunotherapy stops certain cancers from turning off the anticancer immune response
  • Discuss general therapeutic approaches to activating the immune system to treat cancer
  • Answer your questions live during the broadcast!

Featured Speakers:

James P. Allison, Ph.D.
MD Anderson Cancer Center, Houston, TX

Gordon J. Freeman, Ph.D.
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Philip J. Gotwals, Ph.D

Novartis Institutes for BioMedical Research, Cambridge, MA

  

  Watch Now

After you watch the webinar, check out our downloadable Application Notes and Posters on multiplex IHC to characterize immune checkpoint signaling in the tumor microenvironment.

Recent Posts

Research Round-Up: CST® Anti-CAR Linker Antibodies in the Literature

As chimeric antigen receptor (CAR) cell therapies for the treatment of solid tumors, hematologic malignan...
Alexandra Foley Mar 5, 2025

Do You Trust Your Research Antibody?

There’s no getting around it: Selecting the right antibody can make or break your experiment. If the reag...
Alexandra Foley Feb 26, 2025

Why is combining single cell RNA and intracellular signaling data difficult?

What if you could measure RNA, determine cell type, and detect intracellular signaling, all in a single c...
Alexandra Foley Feb 19, 2025